原代細胞市場，規模，佔有率，趨勢，產業分析報告:來源，各類型，各用途，各終端用戶，各地區 - 2025年～2034年的市場預測

根據 Polaris Market Research 的最新研究，預計到 2034 年，原代細胞市場規模將達到 49.5 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

原代細胞是分離的細胞，保留了其來源組織的生理特性，這對於建構逼真的生物模型具有重要價值。這些細胞越來越多地融入個人化醫療，其能夠重現患者特定狀況，從而支持客製化治療策略，這正在推動成長機會。這一趨勢正在透過提高藥物反應預測的準確性和降低副作用風險來改變藥物的發現和開發。隨著醫療保健朝著更精準和個人化的解決方案發展，原代細胞在連接實驗室研究和臨床結果方面發揮關鍵作用。

細胞培養技術的快速發展提高了這些細胞在研究和治療方面的實用性、穩定性和可擴展性。近期的創新，例如3D培養系統、先進的共培養方法和自動化技術，正在提高原代細胞研究的有效性和可重複性。這些進步解決了原代細胞壽命短和多變性等傳統局限性，同時為再生醫學、疾病建模和毒性測試開闢了新的途徑。因此，原代細胞正成為下一代生物醫學研究和治療開發的重要工具。

原代細胞市場報告重點

按來源劃分，人體來源部門市場將在2024年佔69.38%的主導收入佔有率，這得益於其在精確模擬人體生物過程方面具有卓越的生理相關性。

按類型劃分，肝細胞部門市場預計將以12.6%的複合年增長率增長，這得益於肝細胞在藥物代謝和毒性測試中的重要作用。

到2024年，北美將以51.46%的市佔率引領全球市場，這得益於其先進的醫療基礎設施和強大的生物製藥研發部門。

預計亞太市場將以13.1%的最高複合年增長率成長，這得益於生物醫學科學投資的增加和製藥製造業的擴張。

全球主要市場參與者包括 ALLCells、Axol Bioscience Ltd、Cell Applications, Inc、Cell Biologics, Inc、Creative Bioarray、Cureline、Lonza Group, AG、Merck KGaA、Pelobiotech、PromoCell、Sigma-Aldrich、Stem Cell Technologies、Thermo Fisher Scient Technologies Inc., ZenrBio.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 原代細胞市場洞察

• 原代細胞 - 產業概述
• 原代細胞市場動態
  • 促進因素和機會
    • 慢性病發生率上升和癌症
    • 細胞培養技術與研究工具的進展
    • 2024 年主要資助計畫範例
    • 全球資助類型（按年份）
    • 不斷擴大的全球臨床格局
    • 不斷擴展的細胞培養技術應用組合
    • 疫苗生產、人工器官、培養基和生物製藥的需求不斷增長
  • 阻礙因素和課題
    • 可擴充性問題
    • 關於動物的倫理問題
• 波特五力模型分析
  • 供應商議價能力（中）
  • 新進入者的威脅（低）
  • 買方議價能力（中）
  • 替代品的威脅（中）
  • 現有企業之間的競爭（高）
• PEST 分析
• COVID-19 影響分析及產業趨勢

第5章 原代細胞市場評估:來源

• 簡介
• 動物來源
• 人來源

第6章 原代細胞市場評估:各類型

• 簡介
• 造血
• 肝細胞
• 腎細胞
• 消化管細胞
• 皮膚細胞
• 肺細胞
• 其他的類型

第7章 原代細胞市場評估:各用途

• 簡介
• ADME毒性實驗
• 其他用途

第8章 原代細胞市場評估:各終端用戶

• 簡介
• 製藥·生物科技企業
• 研究機關

第9章 原代細胞市場評估:各地區

• 簡介
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
• 南美
  • 巴西
  • 墨西哥
• 中東·非洲

第10章 競爭情形

• 產品發布是企業最常使用的策略
• 產品銷售
• 聯盟/合作/協定/公開

第11章 企業簡介

• Cell Biologics, Inc.
• ZenBio, Inc.
• Stem Cell Technologies
• Sigma-Aldrich
• Thermo Fisher Scientific
• Cureline
• American Type Culture Collection
• Cell Applications, Inc.
• Pelobiotech
• Merck KGaA
• Axol Bioscience Ltd
• PromoCell
• ALLCells
• Lonza Group, AG
• Creative Bioarray

The primary cells market size is expected to reach USD 4.95 billion by 2034, according to a new study by Polaris Market Research. The report "Primary Cells Market Share, Size, Trends, Industry Analysis Report: By Source, By Type (Animal Source, Human Source), By Application, By End Users, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Primary cells are isolated cells that retain the physiological properties of their tissue of origin, making them highly valuable for creating realistic biological models. The growing integration of these cells in personalized medicine, where their ability to replicate patient-specific conditions supports tailored therapeutic strategies, drives the growth opportunities. This trend is reshaping drug discovery and development by improving accuracy in predicting drug responses and reducing the risks of adverse effects. Primary cells are playing a critical role in bridging laboratory research with clinical outcomes as healthcare moves towards more precise and individualized solutions.

The rapid advancement of cell culture technologies has enhanced the utility, stability, and scalability of these cells for research and therapeutic purposes. Modern innovations such as 3D culture systems, advanced co-culture methods, and automation have improved the relevance and reproducibility of studies involving primary cells. These advancements address the traditional limitations of short lifespan and variability and also open new avenues in regenerative medicine, disease modeling, and toxicology testing. As a result, primary cells are becoming essential tools for next-generation biomedical research and therapy development.

Primary Cells Market Report Highlights

In terms of source, the human source segment held a dominant 69.38% revenue share in 2024, owing to its superior physiological relevance for accurately modeling human biological processes.

Based on type, the hepatocytes segment is projected to grow at the fastest CAGR of 12.6%, driven by their critical role in drug metabolism and toxicity testing.

North America led the global market with a 51.46% share in 2024, attributed to its advanced healthcare infrastructure and robust biopharmaceutical R&D sector.

The Asia Pacific market is expected to grow at the highest CAGR of 13.1%, propelled by rising biomedical investments and expanding pharmaceutical manufacturing.

A few global key market players include ALLCells; Axol Bioscience Ltd; Cell Applications, Inc.; Cell Biologics, Inc.; Creative Bioarray; Cureline; Lonza Group, AG; Merck KGaA; Pelobiotech; PromoCell; Sigma-Aldrich; Stem Cell Technologies; Thermo Fisher Scientific; and ZenBio, Inc.

Polaris Market Research has segmented the market report on the basis of source, type, application, end users, and region:

By Source Outlook (Revenue, USD Billion, 2020-2034)

Animal Source

Human Source

By Type Outlook (Revenue, USD Billion, 2020-2034)

Hematopoietic

Hepatocytes

Renal Cells

Gastrointestinal Cells

Skin Cells

Lung Cells

Other Types

By Application Outlook (Revenue, USD Billion, 2020-2034)

ADME Toxicology Testing

Other Applications

By End Users Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology Companies

Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Primary Cells Market Insights

• 4.1 Primary Cells - Industry snapshot
• 4.1 Primary Cells Market Dynamics
  • 4.1.1 Drivers and Opportunities
    • 4.1.1.1 Rising Prevalence of Chronic Diseases and Cancer
    • 4.1.1.2 Advancements in Cell Culture Technologies and Research Tools
    • 4.1.1.2.1 Examples of key financing initiatives, 2024
    • 4.1.1.2.2 Total Global Financings Type by Year
    • 4.1.1.2.3 Widening Global Clinical Landscape
    • 4.1.1.3 Widening Application Portfolio Of Cell Culture Technology
    • 4.1.1.4 Rising Demand For Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
  • 4.1.2 Restraints and Challenges
    • 4.1.2.1 Scalability Issues
    • 4.1.2.2 Ethical Concerns Pertaining To Animals
• 4.2 Primary Cells Market - Porter's Five Forces
  • 4.2.1 Bargaining Power of Suppliers (Moderate)
  • 4.2.2 Threats of New Entrants: (Low)
  • 4.2.3 Bargaining Power of Buyers (Moderate)
  • 4.2.4 Threat of Substitute (Moderate)
  • 4.2.5 Rivalry among existing firms (High)
• 4.3 Primary Cells Market - PEST Analysis
• 4.4 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Primary Cells Market Assessment by Source

• 5.1 Introduction
• 5.2 Animal Source
• 5.3 Human Source

Chapter 6. Primary Cells Market Assessment by Type

• 6.1 Introduction
• 6.2 Hematopoietic
• 6.3 Hepatocytes
• 6.4 Renal Cells
• 6.5 Gastrointestinal Cells
• 6.6 Skin Cells
• 6.7 Lung Cells
• 6.8 Other Types

Chapter 7. Hepatocytes Market Assessment by Application

• 7.1 Introduction
• 7.2 ADME Toxicology Testing
• 7.3 Other Applications

Chapter 8. Primary Cells Market Assessment by End-Users

• 8.1 Introduction
• 8.2 Pharmaceutical & Biotechnology Companies
• 8.3 Research Institutes

Chapter 9. Primary Cells Market Assessment by Region

• 9.1 Introduction
• 9.2 Primary Cells Market - North America
  • 9.2.1 Primary Cells Market - U.S.
  • 9.2.2 Primary Cells Market - Canada
• 9.3 Primary Cells Market - Europe
  • 9.3.1 Primary Cells Market - Germany
  • 9.3.2 Primary Cells Market - UK
  • 9.3.3 Primary Cells Market - France
  • 9.3.4 Primary Cells Market - Italy
• 9.4 Primary Cells Market - Asia Pacific
  • 9.4.1 Primary Cells Market - China
  • 9.4.2 Primary Cells Market - India
  • 9.4.3 Primary Cells Market - Japan
  • 9.4.4 Primary Cells Market - South Korea
• 9.5 Primary Cells Market - Latin America
  • 9.5.1 Primary Cells Market - Brazil
  • 9.5.2 Primary Cells Market - Mexico
• 9.6 Primary Cells Market - Middle East & Africa

Chapter 10. Competitive Landscape

• 10.1 Product Launch is the Best Adopted Strategy by the Companies
• 10.2 Product Launch
• 10.3 Partnerships/Collaborations/Agreements/Exhibitions

Chapter 11. Company Profiles

• 11.1 Cell Biologics, Inc.
  • 11.1.1 Business Overview
  • 11.1.2 Financial Snapshot
  • 11.1.3 Products and Services
• 11.2 ZenBio, Inc.
  • 11.2.1 Business Overview
  • 11.2.2 Financial Snapshot
  • 11.2.3 Products and Services
• 11.3 Stem Cell Technologies
  • 11.3.1 Business Overview
  • 11.3.2 Financial Snapshot
  • 11.3.3 Products and Services
  • 11.3.4 Recent Developments
• 11.4 Sigma-Aldrich
  • 11.4.1 Business Overview
  • 11.4.2 Financial Snapshot
  • 11.4.3 Products and Services
  • 11.4.4 Recent Developments
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Business Overview
  • 11.5.2 Financial Snapshot
  • 11.5.3 Products and Services
  • 11.5.4 Recent Developments
• 11.6 Cureline
  • 11.6.1 Business Overview
  • 11.6.2 Financial Snapshot
  • 11.6.3 Products and Services
  • 11.6.4 Recent Developments
• 11.7 American Type Culture Collection
  • 11.7.1 Business Overview
  • 11.7.2 Financial Snapshot
  • 11.7.3 Products and Services
  • 11.7.4 Recent Developments
• 11.8 Cell Applications, Inc.
  • 11.8.1 Business Overview
  • 11.8.2 Financial Snapshot
  • 11.8.3 Products and Services
• 11.9 Pelobiotech
  • 11.9.1 Business Overview
  • 11.9.2 Financial Snapshot
  • 11.9.3 Products and Services
  • 11.9.4 Recent Developments
• 11.10 Merck KGaA
  • 11.10.1 Business Overview
  • 11.10.2 Financial Snapshot
  • 11.10.3 Products and Services
  • 11.10.4 Recent Developments
• 11.11 Axol Bioscience Ltd
  • 11.11.1 Business Overview
  • 11.11.2 Financial Snapshot
  • 11.11.3 Products and Services
  • 11.11.4 Recent Developments
• 11.12 PromoCell
  • 11.12.1 Business Overview
  • 11.12.2 Financial Snapshot
  • 11.12.3 Products and Services
  • 11.12.4 Recent Developments
• 11.13 ALLCells
  • 11.13.1 Business Overview
  • 11.13.2 Financial Snapshot
  • 11.13.3 Products and Services
  • 11.13.4 Recent Developments
• 11.14 Lonza Group, AG
  • 11.14.1 Business Overview
  • 11.14.2 Financial Snapshot
  • 11.14.3 Products and Services
  • 11.14.4 Recent Developments
• 11.15 Creative Bioarray
  • 11.15.1 Business Overview
  • 11.15.2 Financial Snapshot
  • 11.15.3 Products and Services

List of Tables

• Table 1 Global Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 1 Global Primary Cells Market, by Animal Source, 2020 - 2034 (USD Billion)
• Table 2 Global Primary Cells Market, by Human Source, 2020 - 2034 (USD Billion)
• Table 3 Global Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 4 Global Primary Cells Market, by Hematopoietic, 2020 - 2034 (USD Billion)
• Table 5 Global Primary Cells Market, by Hepatocytes, 2020 - 2034 (USD Billion)
• Table 6 Global Primary Cells Market, by Renal Cells, 2020 - 2034 (USD Billion)
• Table 7 Global Primary Cells Market, by Gastrointestinal Cells, 2020 - 2034 (USD Billion)
• Table 8 Global Primary Cells Market, by Skin Cells, 2020 - 2034 (USD Billion)
• Table 9 Global Primary Cells Market, by Lung Cells, 2020 - 2034 (USD Billion)
• Table 10 Global Primary Cells Market, by Other Types, 2020 - 2034 (USD Billion)
• Table 11 Global Hepatocytes Market Assessment, by Application, 2020 - 2034 (USD Billion)
• Table 12 Global Hepatocytes Market, by ADME Toxicology Testing, 2020 - 2034 (USD Billion)
• Table 13 Global Hepatocytes Market, by Other Applications, 2020 - 2034 (USD Billion)
• Table 14 Global Primary Cells Market, By End-Users, 2020 - 2034 (USD Billion)
• Table 15 Global Primary Cells Market, by Pharmaceutical & Biotechnology Companies, 2020 - 2034 (USD Billion)
• Table 16 Global Primary Cells Market, by Research Institutes, 2020 - 2034 (USD Billion)
• Table 17 Primary Cells Market Assessment, By Geography, 2020 - 2034 (USD Billion)
• Table 18 North America Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 19 North America Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 20 North America Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 21 North America Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 22 U.S. Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 23 U.S. Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 24 U.S. Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 25 U.S. Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 26 Canada Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 27 Canada Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 28 Canada Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 29 Canada Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 30 Europe Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 31 Europe Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 32 Europe Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 33 Europe Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 34 Germany Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 35 Germany Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 36 Germany Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 37 Germany Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 38 UK Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 39 UK Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 40 UK Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 41 UK Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 42 France Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 43 France Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 44 France Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 45 France Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 46 Italy Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 47 Italy Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 48 Italy Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 49 Italy Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 50 Asia Pacific Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 51 Asia Pacific Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 52 Asia Pacific Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 53 Asia Pacific Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 54 China Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 55 China Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 56 China Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 57 China Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 58 India Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 59 India Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 60 India Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 61 India Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 62 Japan Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 63 Japan Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 64 Japan Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 65 Japan Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 66 South Korea Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 67 South Korea Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 68 South Korea Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 69 South Korea Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 70 Latin America Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 71 Latin America Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 72 Latin America Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 73 Latin America Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 74 Brazil Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 75 Brazil Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 76 Brazil Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 77 Brazil Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 78 Mexico Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 79 Mexico Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 80 Mexico Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 81 Mexico Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)
• Table 82 Middle East & Africa Primary Cells Market, By Source, 2020 - 2034 (USD Billion)
• Table 83 Middle East & Africa Primary Cells Market, By Type, 2020 - 2034 (USD Billion)
• Table 84 Middle East & Africa Hepatocytes Market, By Application, 2020 - 2034 (USD Billion)
• Table 85 Middle East & Africa Primary Cells Market, By End-Use, 2020 - 2034 (USD Billion)

List of Figures

• Figure 1. Executive Summary
• Figure 2. Research Methodology: Top Down & Bottom-Up Approach
• Figure 3. Market by Geography
• Figure 4. Total Clinical Trials Underway in 2024
• Figure 5. Porter's Five Forces
• Figure 6. Primary Cells Market - PEST Analysis
• Figure 7. Market by Source
• Figure 8. Global Primary Cells Market, By Source, 2024 & 2034 (USD Billion)
• Figure 9. Market by Type
• Figure 10. Global Primary Cells Market, By Type, 2024 & 2034 (USD Billion)
• Figure 11. Market by Application
• Figure 12. Global Hepatocytes Market Assessment, by Application, 2024 & 2034 (USD Billion)
• Figure 13. Market by End-Users
• Figure 14. Global Primary Cells Market, By End-Users, 2024 & 2034 (USD Billion)
• Figure 15. Primary Cells Market Assessment, By Geography, 2024 & 2034 (USD Billion)
• Figure 16. Strategic Analysis - Primary Cells